Authors
Loading...
Randomized trial finds neutral endopeptidase inhibition enhances blood pressure-lowering effects of natriuretic peptides in transgenic rats, suggesting a potential therapy for hypertension.
Wegner et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: